European CNS Specialist Neuraxpharm Expands Southern European Presence with Expansion into Portugal

LANGENFELD, GermanyNov. 28, 2019 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), announces expansion of its operations in Southern Europe with the launch of Neuraxpharm Portugal. Based in Lisbon, Neuraxpharm Portugal will be part of the Company’s Southern European Region that comprises ItalySpain and now Portugal.

Neuraxpharm aims to build its position as a CNS specialist in Portugal offering its wide portfolio of branded and consumer healthcare products in the Portuguese market for the first time. Neuraxpharm will leverage its industry networks and CNS expertise to make its extensive portfolio available to patients. The company is planning the first commercial launch in December this year with a probiotic product.

Read more